샘플 요청 목록

 카트 문의
시장보고서
상품코드
1659413

세계의 분자생물학용 효소, 키트, 시약 시장

Molecular Biology Enzymes and Kits & Reagents
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 89 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 분자생물학용 효소, 키트, 시약 시장은 2030년까지 705억 달러에 도달

2024년에 324억 달러로 추정되는 세계의 분자생물학용 효소·키트·시약 시장은 2030년에는 705억 달러에 달하며, 분석 기간인 2024-2030년의 CAGR은 13.9%로 성장할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 분자생물학 키트 & 시약은 CAGR 14.6%를 기록하며, 분석 기간 종료시에는 648억 달러에 달할 것으로 예측됩니다. 분자생물학 효소 분야의 성장률은 분석 기간 중 CAGR 7.0%로 추정됩니다.

미국 시장은 90억 달러로 추정, 중국은 CAGR 13.2%로 성장할 것으로 예측

미국의 분자생물학 효소 및 키트·시약 시장은 2024년에 90억 달러로 추정됩니다. 세계 2위의 경제대국인 중국은2024-2030년 CAGR을 13.2%로 견인하며, 2030년까지 108억 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 12.0%와 11.5%로 예측됩니다. 유럽에서는 독일이 CAGR 약 9.5%로 성장할 것으로 예측됩니다.

세계의 분자생물학용 효소, 키트, 시약 시장 - 주요 동향과 시장 성장 촉진요인 정리

분자생물학 효소, 키트, 시약은 어떻게 연구에 혁명을 일으키고 있는가?

분자생물학 효소, 키트 및 시약은 DNA 시퀀싱, 중합효소 연쇄반응(PCR), 유전자 클로닝, 단백질 분석 등 다양한 연구 용도에서 사용되는 필수적인 툴입니다. DNA 중합효소, 제한효소, 리가제 등 분자생물학용 효소는 핵산 조작 및 분석을 용이하게 하고, 질병의 원인 규명, 새로운 치료법 개발 및 질병을 연구할 수 있도록 도와줍니다. 질병의 해명, 새로운 치료법 개발, 유전공학의 진보에 필수적입니다. 분자생물학용 효소, 키트, 시약 시장은 유전체학, 단백질체학, 맞춤의료 연구 활동 증가로 확대되고 있습니다. 유전자 질환의 해명과 표적 치료법 개발에 대한 관심이 높아지면서 첨단 분자생물학 툴에 대한 수요가 증가하고 있습니다. 제약기업과 연구기관들은 신약개발을 가속화하고 진단 기술을 향상시키기 위해 분자생물학 연구에 많은 투자를 하고 있으며, 이는 시장 성장을 더욱 촉진하고 있습니다.

분자생물학 효소, 키트, 시약 시장을 주도하는 동향은?

분자생물학 효소, 키트 및 시약 시장에 영향을 미치는 주요 동향으로는 차세대 염기서열 분석기(NGS)의 부상, 생명공학 및 생명과학 연구의 성장, 개인맞춤형 의료에 대한 관심 증가 등이 있습니다. NGS 플랫폼과 기술의 급속한 발전은 기업이 시퀀싱 용도에 맞는 특수 효소 및 키트를 개발할 수 있는 기회를 창출하고 있습니다. 개인의 유전적 체질에 따라 치료를 맞춤화하는 맞춤형 의료에 대한 관심이 높아지면서 분자생물학 툴에 대한 수요도 증가하고 있습니다. 연구개발은 이러한 툴을 사용하여 유전자 변이를 연구하고 정밀 치료법을 개발하고 있습니다. 또한 생명공학 산업의 확장으로 연구개발 자금이 증가하고 고품질 분자생물학 제품에 대한 수요가 증가하고 있는 것도 시장 개척에 기여하고 있습니다.

시장 세분화는 분자 생물학 효소, 키트 및 시약에 어떤 영향을 미치는가?

제품 카테고리에는 효소, 키트, 시약이 있으며, 효소는 다양한 분자생물학적 기법에 광범위하게 사용되므로 가장 큰 점유율을 차지하고 있습니다. 이들 제품의 용도는 연구, 진단, 치료제 개발 등 다양하며, 연구실 및 학술기관이 주요 사용자입니다. 최종사용자 부문에는 학술 및 연구 기관, 병원 및 진단센터, 제약 및 생명공학 기업이 포함됩니다. 제약 및 생명공학 분야는 신약개발에 대한 투자가 증가함에 따라 괄목할 만한 성장을 보이고 있습니다. 지역적으로는 북미가 첨단 연구 인프라와 생명과학에 대한 막대한 자금 지원으로 시장을 주도하고 있습니다. 반면, 아시아태평양은 연구 활동 증가와 정부의 바이오테크놀러지 개발에 대한 지원으로 빠르게 성장하고 있습니다.

분자생물학용 효소, 키트, 시약 시장의 성장을 가속하는 요인은 무엇인가?

분자생물학용 효소, 키트 및 시약 시장의 성장은 유전자 연구에 대한 수요 증가, 분자생물학 기술의 발전, 맞춤형 의료에 대한 관심 증가 등 여러 요인에 의해 주도되고 있습니다. 유전체 및 단백질체학 연구의 확대는 분자생물학 툴에 대한 수요를 증가시키고 있으며, NGS 및 기타 분자 기술의 발전은 특수 제품 개발의 기회를 창출하고 있습니다. 또한 정밀의료 증가로 인해 분자생물학적 효소, 키트 및 시약이 표적 치료 및 진단 개발에 활용되고 있습니다.

부문

제품(키트/시약, 효소);용도(PCR, 시퀀싱, 클로닝, 후성유전학, 기타 용도);최종 용도(학술/연구, 제약/바이오, 병원/진단, 기타 최종 용도)

조사 대상 기업의 예(주목 33사)

  • Affymetrix, Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Enzymatics
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • LGC Limited
  • Merck KGaA
  • New England Biolabs
  • Promega Corporation
  • QIAGEN
  • Sigma-Aldrich Co. LLC
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장의 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

KSA 25.03.07

Global Molecular Biology Enzymes and Kits & Reagents Market to Reach US$70.5 Billion by 2030

The global market for Molecular Biology Enzymes and Kits & Reagents estimated at US$32.4 Billion in the year 2024, is expected to reach US$70.5 Billion by 2030, growing at a CAGR of 13.9% over the analysis period 2024-2030. Molecular Biology Kits & Reagents, one of the segments analyzed in the report, is expected to record a 14.6% CAGR and reach US$64.8 Billion by the end of the analysis period. Growth in the Molecular Biology Enzymes segment is estimated at 7.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$9.0 Billion While China is Forecast to Grow at 13.2% CAGR

The Molecular Biology Enzymes and Kits & Reagents market in the U.S. is estimated at US$9.0 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$10.8 Billion by the year 2030 trailing a CAGR of 13.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.0% and 11.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.5% CAGR.

Global Molecular Biology Enzymes and Kits & Reagents Market - Key Trends and Drivers Summarized

How Are Molecular Biology Enzymes, Kits & Reagents Revolutionizing Research?

Molecular biology enzymes, kits, and reagents are essential tools used in various research applications, including DNA sequencing, polymerase chain reactions (PCR), gene cloning, and protein analysis. These products play a critical role in life sciences, biotechnology, and pharmaceutical research, enabling scientists to study the structure, function, and interactions of genetic material. Molecular biology enzymes, such as DNA polymerases, restriction enzymes, and ligases, facilitate the manipulation and analysis of nucleic acids, which is crucial for understanding diseases, developing new treatments, and advancing genetic engineering. The market for molecular biology enzymes, kits, and reagents is expanding due to increasing research activities in genomics, proteomics, and personalized medicine. With the growing focus on understanding genetic disorders and developing targeted therapies, there is a rising demand for advanced molecular biology tools. Pharmaceutical companies and research institutions are investing heavily in molecular biology research to accelerate drug discovery and improve diagnostic techniques, further fueling the market's growth.

What Trends Are Driving the Molecular Biology Enzymes, Kits & Reagents Market?

Key trends influencing the molecular biology enzymes, kits, and reagents market include the rise of next-generation sequencing (NGS), the growth of biotechnology and life sciences research, and the increasing focus on personalized medicine. NGS technologies have revolutionized genomics research by enabling high-throughput analysis of DNA sequences, driving the demand for molecular biology enzymes and reagents. The rapid advancements in NGS platforms and techniques are creating opportunities for companies to develop specialized enzymes and kits tailored for sequencing applications. The growing emphasis on personalized medicine, which involves tailoring medical treatments based on an individual's genetic makeup, is also boosting the demand for molecular biology tools. Researchers are using these tools to study genetic variations and develop precision therapies. Additionally, the expansion of the biotechnology industry, with increased funding for research and development, is further contributing to market growth by driving demand for high-quality molecular biology products.

How Do Market Segments Impact Molecular Biology Enzymes, Kits & Reagents?

Product categories include enzymes, kits, and reagents, with enzymes accounting for the largest share due to their extensive use in various molecular biology techniques. Applications of these products span across research, diagnostics, and therapeutic development, with research laboratories and academic institutions being the primary users. The end-user segment includes academic and research institutes, hospitals and diagnostic centers, and pharmaceutical and biotechnology companies. The pharmaceutical and biotechnology segment is witnessing significant growth due to increasing investments in drug discovery and development. Geographically, North America dominates the market due to advanced research infrastructure and substantial funding for life sciences. Meanwhile, the Asia-Pacific region is experiencing rapid growth, driven by increasing research activities and government support for biotechnology development.

What Factors Are Driving the Growth in the Molecular Biology Enzymes, Kits & Reagents Market?

The growth in the molecular biology enzymes, kits, and reagents market is driven by several factors, including the rising demand for genetic research, advancements in molecular biology techniques, and the increasing focus on personalized medicine. The expansion of genomics and proteomics research is boosting the demand for molecular biology tools. Advancements in NGS and other molecular techniques are creating opportunities for the development of specialized products. Furthermore, the growing trend of precision medicine is encouraging the use of molecular biology enzymes, kits, and reagents for the development of targeted therapies and diagnostics.

SCOPE OF STUDY:

The report analyzes the Molecular Biology Enzymes and Kits & Reagents market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Kits & Reagents, Enzymes); Application (PCR, Sequencing, Cloning, Epigenetics, Other Applications); End-Use (Academic & Research, Pharma & Biotech, Hospital & Diagnostics, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 33 Featured) -

  • Affymetrix, Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Enzymatics
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • LGC Limited
  • Merck KGaA
  • New England Biolabs
  • Promega Corporation
  • QIAGEN
  • Sigma-Aldrich Co. LLC
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Molecular Biology Enzymes and Kits & Reagents - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Genomics and Proteomics Research Spurs Growth in Molecular Biology Enzymes and Kits & Reagents Market
    • Technological Advancements in High-Fidelity Enzymes and PCR Kits Strengthen Business Case for Adoption
    • Growing Focus on Personalized Medicine and Diagnostic Applications Expands Addressable Market
    • Expansion of Molecular Biology Enzymes and Kits in Pharmaceutical and Biotechnology Industries Fuels Market Growth
    • Increasing Adoption of NGS (Next-Generation Sequencing) and CRISPR Technologies Expands Market Opportunities
    • Technological Innovations in Recombinant Enzymes and High-Throughput Kits Propel Market Expansion
    • Rising Focus on Enhancing Accuracy and Reproducibility in Molecular Experiments Drives Demand for Enzymes and Kits
    • Growing Use of Molecular Biology Enzymes and Kits in Agriculture and Food Safety Testing Expands Market Potential
    • Focus on Reducing Experiment Time and Improving Workflow Efficiency Strengthens Market for Molecular Biology Reagents
    • Rising Adoption of Molecular Biology Enzymes in Cancer Research and Biomarker Discovery Expands Addressable Market
    • Technological Advancements in Point-of-Care Molecular Diagnostic Kits Propel Market Growth
    • Expansion of Molecular Biology Reagents in Environmental and Microbial Studies Expands Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Molecular Biology Enzymes and Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Enzymes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Enzymes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Enzymes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Academic & Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Academic & Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Academic & Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Hospital & Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Hospital & Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Hospital & Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Pharma & Biotech by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Pharma & Biotech by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Pharma & Biotech by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 27: World 15-Year Perspective for PCR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Cloning by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Cloning by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 30: World 15-Year Perspective for Cloning by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Epigenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Epigenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 33: World 15-Year Perspective for Epigenetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 35: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 36: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 37: World Molecular Biology Enzymes and Kits & Reagents Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Molecular Biology Enzymes and Kits & Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Molecular Biology Enzymes and Kits & Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Molecular Biology Enzymes and Kits & Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Molecular Biology Enzymes and Kits & Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Molecular Biology Enzymes and Kits & Reagents by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Molecular Biology Enzymes and Kits & Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Molecular Biology Enzymes and Kits & Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Molecular Biology Enzymes and Kits & Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Europe 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Europe 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Europe 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Molecular Biology Enzymes and Kits & Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Asia-Pacific 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Asia-Pacific 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Asia-Pacific 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of World 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of World 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of World 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제